DNA 시퀀싱 시장 : 시장 규모, 점유율, 성장 분석 - 제품 및 서비스별, 기술별, 워크플로우별, 용도별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)
DNA Sequencing Market Size, Share, Growth Analysis, By Product & Service (Instruments, Consumables), By Technology, By Workflow, By Application, By End-use, By Region - Industry Forecast 2024-2031
상품코드:1619281
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 165 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 DNA 시퀀싱 시장 규모는 2022년에 105억 달러로 평가되었고, 2023년 122억 9,000만 달러에서 2031년에는 440억 달러로 성장할 전망이며, 예측 기간(2024-2031년)의 CAGR은 17.12%로 성장할 전망입니다.
미국의 DNA 시퀀싱 시장은 차세대 및 전체 유전체 분석 기술의 급속한 진보에 힘입어 강력한 성장이 예상되고 있습니다. 일루미나의 NGS와 같은 혁신은 병렬 처리 기능을 통해 시퀀스의 처리량과 속도를 대폭 향상시키고 여러 DNA 부문의 동시 해석을 가능하게 함으로써 유전체에 혁명을 가져왔습니다. 이러한 데이터 처리의 고속화로 연구자와 헬스케어 전문가는 진단 및 개별화 의료를 위해 중요한 유전적 인사이트를 효율적으로 이끌어 낼 수 있습니다. 이러한 경향을 나타내는 것으로서 일루미나는 2023년 3월에 임상 NGS 데이터 처리를 효율화하는 Connected Insights 클라우드 베이스 프로그램을 개시했습니다. 게놈 연구와 개별화 의료에 대한 관심이 높아짐에 따라 DNA 시퀀스는 헬스케어의 필수적인 도구로 등장하여 진단, 치료 전략, 질병 예방에 있어서의 유망한 진전에 대한 길을 개척하고 있습니다.
목차
서문
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터 및 1차 데이터의 방법
시장 규모 예측
시장의 전제조건 및 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학 및 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인 및 과제
Porter's Five Forces 분석과 영향
경쟁 기업간 경쟁 관계
대체품의 위협
구매자의 협상력
신규 진입업자의 위협
공급기업의 협상력
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
기술의 진보
규제 상황
사례 연구
고객 및 구매 기준 분석
DNA 시퀀싱 시장 규모 : 제품 및 서비스별 CAGR(2024-2031년)
시장 개요
소모품
기기
서비스
DNA 시퀀싱 시장 규모 : 기술별 CAGR(2024-2031년)
시장 개요
산가 시퀀싱
차세대 시퀀싱
전체 유전체 서열 분석(WGS)
전체 엑솜 서열 분석(WES)
타겟 시퀀싱과 리시퀀싱
3세대 시퀀싱
단일 분자 실시간 시퀀싱(SMRT)
나노포어 시퀀싱
DNA 시퀀싱 시장 규모 : 워크플로우별 CAGR(2024-2031년)
시장 개요
프리 시퀀싱
시퀀싱
데이터 분석
DNA 시퀀싱 시장 규모 : 용도별 CAGR(2024-2031년)
시장 개요
종양학
리프로덕티브 헬스
임상 연구
아그리유전체학와 법의학
HLA 타이핑 및 면역시스템 모니터링
군유전체학, 역학, 의약품 개발
소비자 유전체학
기타
DNA 시퀀싱 시장 규모 : 최종 용도별 CAGR(2024-2031년)
시장 개요
학술연구
임상 연구
병원 및 클리닉
제약 및 바이오테크놀러지 기업
기타 사용자
DNA 시퀀싱 시장 규모 : 지역별 CAGR(2024-2031년)
북미
미국
캐나다
유럽
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2021-2023년)
주요 기업 프로파일
Illumina, Inc.
Thermo Fisher Scientific
Pacific Biosciences(PacBio)
Oxford Nanopore Technologies
Qiagen
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Element Biosciences
MGI(BGI Group)
Genewiz
Macrogen
OncoDNA
Hamilton Thorne
DNASTAR
Eurofins GATC Biotech
Roche Diagnostics
Wasatch BioLabs
Integrated DNA Technologies(IDT)
Genomatic AG
결론 및 권장사항
AJY
영문 목차
영문목차
Global DNA Sequencing Market size was valued at USD 10.5 billion in 2022 and is poised to grow from USD 12.29 billion in 2023 to USD 44 billion by 2031, growing at a CAGR of 17.12% in the forecast period (2024-2031).
The US DNA sequencing market is set for robust growth, fueled by rapid advancements in Next-Generation and Whole-Genome Sequencing technologies. Innovations like Illumina's NGS have revolutionized genomics by significantly enhancing sequencing throughput and speed through parallel processing capabilities, enabling the analysis of multiple DNA segments simultaneously. This acceleration in data processing empowers researchers and healthcare professionals to extract critical genetic insights for diagnostics and personalized medicine effectively. Illustrating this trend, Illumina launched its Connected Insights cloud-based program in March 2023 to streamline clinical NGS data processing. As interest in genomic research and personalized medicine grows, DNA sequencing emerges as an indispensable tool in healthcare, paving the way for promising advancements in diagnostics, therapeutic strategies, and disease prevention.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dna Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Dna Sequencing Market Segmental Analysis
Global DNA Sequencing Market is segmented by Product & Service, Technology, Workflow, Application, End-use and region. Based on Product & Service, the market is segmented into Consumables, Instruments, Services. Based on Technology, the market is segmented into Sanger Sequencing, Next-Generation Sequencing, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing, Third Generation Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing. Based on Workflow, the market is segmented into Grade. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Others. Based on End-use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Dna Sequencing Market
The primary catalyst propelling the DNA sequencing market is the increasing emphasis on personalized therapy. As modern healthcare shifts towards customized treatments, comprehensive genetic information becomes essential. DNA sequencing enables healthcare providers to tailor therapies to individual genetic profiles, enhancing treatment effectiveness while minimizing adverse effects. This demand is particularly pronounced in the oncology field, where precision medicine relies on genetic insights to inform targeted therapies. The rising application of genomics in clinical practices fuels market growth as healthcare systems prioritize precision medicine to improve patient outcomes, thereby driving the need for advanced sequencing technologies and services.
Restraints in the Global Dna Sequencing Market
The global DNA sequencing market is hindered by several constraints, primarily involving the significant costs associated with infrastructure and resource requirements. Despite a general decline in sequencing costs over time, many research institutions and healthcare providers, particularly in underdeveloped nations, encounter substantial challenges in acquiring the essential reagents, advanced equipment, and skilled personnel needed for effective sequencing operations. Moreover, the financial burden of data processing and storage can further escalate operational expenses. These economic limitations often restrict the implementation of cutting-edge sequencing technologies, particularly within smaller laboratories or facilities, thereby adversely affecting industry growth and limiting access to advanced genomic solutions.
Market Trends of the Global Dna Sequencing Market
The Global DNA Sequencing market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) technologies, focusing on enhancing data analysis and interpretation capabilities. These advanced algorithms are poised to accelerate genomic data processing, allowing researchers to extract valuable insights from complex datasets with unprecedented speed and accuracy. This shift is particularly impactful in personalized medicine and clinical diagnostics, where the demand for swift and precise genetic information is growing. As AI and ML continue to evolve, they are expected to drive innovation in DNA sequencing applications, ultimately transforming healthcare into a more data-driven landscape that caters to individualized patient needs.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Customer & Buying Criteria Analysis
Global DNA Sequencing Market Size by Product & Service & CAGR (2024-2031)
Market Overview
Consumables
Instruments
Services
Global DNA Sequencing Market Size by Technology & CAGR (2024-2031)
Market Overview
Sanger Sequencing
Next-Generation Sequencing
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing & Resequencing
Third Generation Sequencing
Single-Molecule Real-Time Sequencing (SMRT)
Nanopore Sequencing
Global DNA Sequencing Market Size by Workflow & CAGR (2024-2031)
Market Overview
Pre-sequencing
Sequencing
Data Analysis
Global DNA Sequencing Market Size by Application & CAGR (2024-2031)
Market Overview
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others
Global DNA Sequencing Market Size by End-use & CAGR (2024-2031)
Market Overview
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other Users
Global DNA Sequencing Market Size & CAGR (2024-2031)
North America, (Product & Service, Technology, Workflow, Application, End-use)
